How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Rodent Brain Matrices Market
- By Rodent Species: Mouse Brain Matrices, Rat Brain Matrices, Hamster Brain Matrices, Guinea Pig Brain Matrices
- By Matrix Type: Pre-cut Brain Matrices, Customizable Brain Matrices, Disposable Brain Matrices, Reusable Brain Matrices
- By Application: Neuroscience Research, Pharmacological Testing, Toxicology Studies, Neuroanatomical Studies, Behavioral Studies
- By Material: Stainless Steel Brain Matrices, Aluminum Brain Matrices, Plastic Brain Matrices, Acrylic Brain Matrices
- By Brain Region Specificity: Whole Brain Matrices, Hippocampus Specific Matrices, Cortex Specific Matrices, Striatum Specific Matrices
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Mouse Brain Matrices leads By Rodent Species at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 13 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Rodent Brain Matrices Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Rodent Species 4
Matrix Type 4
Application 5
Material 4
Brain Region Specificity 4
Companies profiled
Harvard Apparatus
Ted Pella
Kent Scientific Corporation
Electron Microscopy Sciences
World Precision Instruments
CellPoint Scientific
Braintree Scientific
Stoelting
KOPF INSTRUMENTS
ASI-Instruments
Bioanalytical Systems
Zivic Instruments
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Harvard Apparatus
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Ted Pella
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Kent Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Electron Microscopy Sciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →World Precision Instruments
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →CellPoint Scientific
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Braintree Scientific
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Stoelting
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →KOPF INSTRUMENTS
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →ASI-Instruments
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Bioanalytical Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Zivic Instruments
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →RWD Life Science
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,227M by 2033 · 6.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Mouse Brain Matrices55.3
- Rat Brain Matrices13.5
- Hamster Brain Matrices20.0
- Guinea Pig Brain Matrices11.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,243M → $2,044M · 6.4%
Europe$866.4M → $1,426M · 6.4%
Asia Pacific$791.1M → $1,224M · 5.6%
Latin America$489.7M → $801.7M · 6.4%
Middle East and Africa$376.7M → $637.1M · 6.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.442026
6.442027
6.462028
6.472029
6.482030
6.502031
6.522032
6.532033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Harvard Apparatus14.7
- Ted Pella25.1
- Kent Scientific Corporation10.5
- Electron Microscopy Sciences8.2
- World Precision Instruments5.4
- CellPoint Scientific8.0
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Rodent Species25.2%
Matrix Type13.2%
Application10.9%
Material25.0%
Brain Region Specificity25.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.3
- Europe23.2
- Asia Pacific20.0
- Latin America13.1
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Harvard Apparatus | 90 | 86 | 95 | 82 | 96 | 92 | 90 |
| Ted Pella | 80 | 90 | 89 | 68 | 89 | 68 | 81 |
| Kent Scientific Corporation | 64 | 73 | 70 | 74 | 83 | 75 | 73 |
| Electron Microscopy Sciences | 82 | 75 | 62 | 67 | 63 | 81 | 72 |
| World Precision Instruments | 74 | 59 | 63 | 60 | 65 | 55 | 63 |
| CellPoint Scientific | 57 | 54 | 68 | 55 | 63 | 60 | 60 |
| Braintree Scientific | 51 | 55 | 52 | 56 | 65 | 52 | 55 |
| Stoelting | 43 | 48 | 44 | 58 | 49 | 54 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Harvard Apparatus
- Ted Pella
- Kent Scientific Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Harvard Apparatus | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Ted Pella | ◐ | ✓ | ◐ | ◐ | ✓ | − |
| Kent Scientific Corporation | ◐ | − | − | ◐ | ◐ | ✓ |
| Electron Microscopy Sciences | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| World Precision Instruments | ✓ | − | ◐ | ◐ | ✓ | − |
| CellPoint Scientific | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Braintree Scientific | − | ◐ | − | − | ◐ | − |
| Stoelting | ◐ | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Harvard Apparatus90
2Ted Pella81
3Kent Scientific Corporation73
4Electron Microscopy Sciences72
5World Precision Instruments63
6CellPoint Scientific60
7Braintree Scientific55
8Stoelting49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Harvard ApparatusTed Pella
Challenger2
Strong scale, closing on the leaders.
Kent Scientific CorporationElectron Microscopy Sciences
Contender2
Focused players with pockets of strength.
World Precision InstrumentsCellPoint Scientific
Niche2
Specialists in a single segment or region.
Braintree ScientificStoelting
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Rodent Species in North America, then scale across Rodent Brain Matrices Market — a $246M beachhead inside a $3.57B market.
Beachhead (SOM)$246Mobtainable near-term
Serviceable (SAM)$1.43Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Mouse Brain Matrices
Best fit — highest urgency & budget in Rodent Species.
Economic buyer75 fit
Rat Brain Matrices
Strong fit — clear ROI and a fast path to value.
End user66 fit
Hamster Brain Matrices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Rodent Species in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Matrix Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel28%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Rodent Species leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Rodent Brain Matrices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified20%
Evaluation14%
Closed-won7%
$11.8KCAC
$66KLTV
5.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Rodent Brain Matrices Market is a durable-growth opportunity — $847M by 2033, compounding at 7.4%.
TAM · 2025$479Mtoday
TAM · 2033$847Mforecast
CAGR7.4%2027–2033
Cumulative$5.83Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$847MTotal addressable market
SAM$325MServiceable available market
SOM$54MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.4% CAGR
Demand compounds through 2033, outpacing GDP across Rodent Species.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Rodent Species moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$847MLarge & growingTAM by 2033 at 7.4% CAGR
$325MServiceable nowreachable with today’s model
$54MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$661MBear4.8% CAGR
$847MBase7.4% CAGR
$1.08BBull9.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Matrix Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Rodent Brain Matrices Market — a $5.08B market by 2033. Plan: grow share from 6.3% to 11.3%.
Market size · 2033$5.08Btotal addressable
Market CAGR11.1%2027–2033
Target share11.3%from 6.3% today
Revenue ambition$574Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.3% | 11.3% | At risk |
| Revenue | $324M | $574M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 31.5% | 39.7% | On track |
| Customer retention | 86.1% | 94.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Rodent Species
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Matrix Type capability
A defensible second engine — invest in Matrix Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Rodent Species share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Matrix Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $61M capacity & capability investment
- Greenlight bolt-on M&A in Matrix Type
- Authorise North America expansion plan
- Fund R&D program for Rodent Species leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Rodent Brain Matrices Market conversation — a $5.04B market you can size, segment and defend in minutes.
Market size · 2033$5.04Btotal opportunity
Growth11.7%CAGR to 2033
Addressable buyers1,750+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Rodent Species
Goal Grow share in Rodent Species
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 2 mopayback period
$57K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
Harvard ApparatusTed PellaKent Scientific CorporationElectron Microscopy SciencesWorld Precision InstrumentsCellPoint ScientificBraintree ScientificStoelting+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Rodent Brain Matrices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Rodent Brain Matrices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Rocuronium Bromide Injection Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportRocking Shakers Market
Market size, share, segmentation and regional forecast.
$557M market · 2025 base year
View reportRocking Laboratory Shaker Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportRocking Laboratory Mixer Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportRocking Bioreactors Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportRocker Switch Smoke Evacuation Pencil Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportRocker Bioreactor Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportROCK2 Inhibitor Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportRoche Medium Market
Market size, share, segmentation and regional forecast.
$759M market · 2025 base year
View reportRobot System for Cochlear Implantation Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportRobots in Orthopaedic Surgery Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportRobotic X-Ray System Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.